世界の口蹄疫(FMD)ワクチン販売市場2021

QYResearchが発行した調査報告書(QYR21JN7694)
◆英語タイトル:Global Foot and Mouth Disease (FMD) Vaccines Sales Market Report 2021
◆商品コード:QYR21JN7694
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月1日(※2024年版があります。お問い合わせください。)
◆ページ数:140
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の口蹄疫(FMD)ワクチン市場について種類別(緊急式ワクチン、従来式ワクチン)、用途別(牛、豚、羊&山羊、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・口蹄疫(FMD)ワクチン市場の概要
・世界の主要地域別口蹄疫(FMD)ワクチン市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の口蹄疫(FMD)ワクチン市場規模2016-2021:種類別(緊急式ワクチン、従来式ワクチン)
・世界の口蹄疫(FMD)ワクチン市場予測2012-2027:種類別(緊急式ワクチン、従来式ワクチン)
・世界の口蹄疫(FMD)ワクチン市場規模2016-2021:用途別(牛、豚、羊&山羊、その他)
・世界の口蹄疫(FMD)ワクチン市場予測2012-2027:用途別(牛、豚、羊&山羊、その他)
・口蹄疫(FMD)ワクチンのアメリカ市場規模と予測2016-2021
・口蹄疫(FMD)ワクチンのヨーロッパ市場規模と予測2016-2021
・口蹄疫(FMD)ワクチンの中国市場規模と予測2016-2021
・口蹄疫(FMD)ワクチンの日本市場規模と予測2016-2021
・口蹄疫(FMD)ワクチンの東南アジア市場規模と予測2016-2021
・口蹄疫(FMD)ワクチンのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Jinyu Group、Cavet Bio、Indian Immunologicals、Tecon Group、CAHIC、Shen Lian、Biogenesis Bagó、BIGVET Biotech、Boehringer Ingelheim、MSD Animal Health、CEVA、FGBI、Bayer HealthCare、Brilliant Bio Pharma、VECOL、Sanofi (Merial)、VETAL、BVI、LIMOR、ME VAC、Agrovet)
・口蹄疫(FMD)ワクチンの製造コスト分析
・販売チャネル、流通業者、顧客
・口蹄疫(FMD)ワクチンの市場動向・機会・課題
・調査の結論
【レポートの概要】

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
The classification of Foot and Mouth Disease Vaccines includes Emergency Vaccines and Conventional Vaccines, and the proportion of Conventional Vaccines in 2016 is about 70%, and the proportion is decreasing trend from 2012 to 2016.
Foot and Mouth Disease Vaccines are widely used for Cattle, Pig, Sheep & Goat and Others. The most proportion of Foot and Mouth Disease Vaccines is used for Cattle, and the consumption proportion is about 70.2% in 2016. The high adoption in the market segment can be attributed to the presence of an increasing number of cattle to meet the increased demand for its livestock products. Currently, India accounts for the largest cattle inventory worldwide, followed by Brazil and China. With the growing demand for cattle products worldwide, there is an increased need to reduce the impact of FMD outbreaks, leading to high demand for the FMD vaccine.
China region is the largest supplier of Foot and Mouth Disease Vaccines, with a production market share nearly 71.7% in 2016. South America is the second largest supplier of Foot and Mouth Disease Vaccines, enjoying production market share nearly 16.5% in 2016.
China is the largest consumption place, with a consumption market share nearly 69.2% in 2016. Following China, South America is the second largest consumption place with the consumption market share of 20.4%.

Market Analysis and Insights: Global Foot and Mouth Disease (FMD) Vaccines Market
The global Foot and Mouth Disease (FMD) Vaccines market was valued at US$ 1059.2 in 2020 and will reach US$ 1835.8 million by the end of 2027, growing at a CAGR of 9.6% during 2022-2027.

Global Foot and Mouth Disease (FMD) Vaccines Scope and Market Size
The global Foot and Mouth Disease (FMD) Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Foot and Mouth Disease (FMD) Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Emergency Vaccines
Conventional Vaccines

Segment by Application
Cattle
Pig
Sheep & Goat
Others

The Foot and Mouth Disease (FMD) Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Foot and Mouth Disease (FMD) Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Jinyu Group
Cavet Bio
Indian Immunologicals
Tecon Group
CAHIC
Shen Lian
Biogenesis Bagó
BIGVET Biotech
Boehringer Ingelheim
MSD Animal Health
CEVA
FGBI
Bayer HealthCare
Brilliant Bio Pharma
VECOL
Sanofi (Merial)
VETAL
BVI
LIMOR
ME VAC
Agrovet

【レポートの目次】

1 Foot and Mouth Disease (FMD) Vaccines Market Overview
1.1 Foot and Mouth Disease (FMD) Vaccines Product Scope
1.2 Foot and Mouth Disease (FMD) Vaccines Segment by Type
1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Emergency Vaccines
1.2.3 Conventional Vaccines
1.3 Foot and Mouth Disease (FMD) Vaccines Segment by Application
1.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Cattle
1.3.3 Pig
1.3.4 Sheep & Goat
1.3.5 Others
1.4 Foot and Mouth Disease (FMD) Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Foot and Mouth Disease (FMD) Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Foot and Mouth Disease (FMD) Vaccines Price Trends (2016-2027)

2 Foot and Mouth Disease (FMD) Vaccines Estimates and Forecasts by Region
2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Foot and Mouth Disease (FMD) Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Foot and Mouth Disease (FMD) Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2016-2027)
2.4.3 China Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2016-2027)
2.4.6 India Foot and Mouth Disease (FMD) Vaccines Estimates and Projections (2016-2027)
3 Global Foot and Mouth Disease (FMD) Vaccines Competition Landscape by Players
3.1 Global Top Foot and Mouth Disease (FMD) Vaccines Players by Sales (2016-2021)
3.2 Global Top Foot and Mouth Disease (FMD) Vaccines Players by Revenue (2016-2021)
3.3 Global Foot and Mouth Disease (FMD) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Foot and Mouth Disease (FMD) Vaccines as of 2020)
3.4 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Foot and Mouth Disease (FMD) Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Type
4.1 Global Foot and Mouth Disease (FMD) Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2016-2021)
4.2 Global Foot and Mouth Disease (FMD) Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Type (2022-2027)
5 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Application
5.1 Global Foot and Mouth Disease (FMD) Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2016-2021)
5.2 Global Foot and Mouth Disease (FMD) Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Price Forecast by Application (2022-2027)

6 North America Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
6.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Company
6.1.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Company (2016-2021)
6.1.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2016-2021)
6.2 North America Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type
6.2.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application
6.3.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application (2022-2027)

7 Europe Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
7.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Company
7.1.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Company (2016-2021)
7.1.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2016-2021)
7.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type
7.2.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application
7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)

8 China Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
8.1 China Foot and Mouth Disease (FMD) Vaccines Sales by Company
8.1.1 China Foot and Mouth Disease (FMD) Vaccines Sales by Company (2016-2021)
8.1.2 China Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2016-2021)
8.2 China Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type
8.2.1 China Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application
8.3.1 China 310 Sales Breakdown by Application (2016-2021)
8.3.2 China 310 Sales Breakdown by Application (2022-2027)

9 Japan Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
9.1 Japan Foot and Mouth Disease (FMD) Vaccines Sales by Company
9.1.1 Japan Foot and Mouth Disease (FMD) Vaccines Sales by Company (2016-2021)
9.1.2 Japan Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2016-2021)
9.2 Japan Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type
9.2.1 Japan Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
10.1 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales by Company
10.1.1 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia K L Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K L Sales Breakdown by Application (2022-2027)

11 India Foot and Mouth Disease (FMD) Vaccines Market Facts & Figures
11.1 India Foot and Mouth Disease (FMD) Vaccines Sales by Company
11.1.1 India Foot and Mouth Disease (FMD) Vaccines Sales by Company (2016-2021)
11.1.2 India Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2016-2021)
11.2 India Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type
11.2.1 India Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application
11.3.1 India Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Foot and Mouth Disease (FMD) Vaccines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Foot and Mouth Disease (FMD) Vaccines Business
12.1 Jinyu Group
12.1.1 Jinyu Group Corporation Information
12.1.2 Jinyu Group Business Overview
12.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Products Offered
12.1.5 Jinyu Group Recent Development
12.2 Cavet Bio
12.2.1 Cavet Bio Corporation Information
12.2.2 Cavet Bio Business Overview
12.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Products Offered
12.2.5 Cavet Bio Recent Development
12.3 Indian Immunologicals
12.3.1 Indian Immunologicals Corporation Information
12.3.2 Indian Immunologicals Business Overview
12.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Products Offered
12.3.5 Indian Immunologicals Recent Development
12.4 Tecon Group
12.4.1 Tecon Group Corporation Information
12.4.2 Tecon Group Business Overview
12.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Products Offered
12.4.5 Tecon Group Recent Development
12.5 CAHIC
12.5.1 CAHIC Corporation Information
12.5.2 CAHIC Business Overview
12.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Products Offered
12.5.5 CAHIC Recent Development
12.6 Shen Lian
12.6.1 Shen Lian Corporation Information
12.6.2 Shen Lian Business Overview
12.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Products Offered
12.6.5 Shen Lian Recent Development
12.7 Biogenesis Bagó
12.7.1 Biogenesis Bagó Corporation Information
12.7.2 Biogenesis Bagó Business Overview
12.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Products Offered
12.7.5 Biogenesis Bagó Recent Development
12.8 BIGVET Biotech
12.8.1 BIGVET Biotech Corporation Information
12.8.2 BIGVET Biotech Business Overview
12.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Products Offered
12.8.5 BIGVET Biotech Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Corporation Information
12.9.2 Boehringer Ingelheim Business Overview
12.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Products Offered
12.9.5 Boehringer Ingelheim Recent Development
12.10 MSD Animal Health
12.10.1 MSD Animal Health Corporation Information
12.10.2 MSD Animal Health Business Overview
12.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Products Offered
12.10.5 MSD Animal Health Recent Development
12.11 CEVA
12.11.1 CEVA Corporation Information
12.11.2 CEVA Business Overview
12.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Products Offered
12.11.5 CEVA Recent Development
12.12 FGBI
12.12.1 FGBI Corporation Information
12.12.2 FGBI Business Overview
12.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Products Offered
12.12.5 FGBI Recent Development
12.13 Bayer HealthCare
12.13.1 Bayer HealthCare Corporation Information
12.13.2 Bayer HealthCare Business Overview
12.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Products Offered
12.13.5 Bayer HealthCare Recent Development
12.14 Brilliant Bio Pharma
12.14.1 Brilliant Bio Pharma Corporation Information
12.14.2 Brilliant Bio Pharma Business Overview
12.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Products Offered
12.14.5 Brilliant Bio Pharma Recent Development
12.15 VECOL
12.15.1 VECOL Corporation Information
12.15.2 VECOL Business Overview
12.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Products Offered
12.15.5 VECOL Recent Development
12.16 Sanofi (Merial)
12.16.1 Sanofi (Merial) Corporation Information
12.16.2 Sanofi (Merial) Business Overview
12.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Products Offered
12.16.5 Sanofi (Merial) Recent Development
12.17 VETAL
12.17.1 VETAL Corporation Information
12.17.2 VETAL Business Overview
12.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Products Offered
12.17.5 VETAL Recent Development
12.18 BVI
12.18.1 BVI Corporation Information
12.18.2 BVI Business Overview
12.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Products Offered
12.18.5 BVI Recent Development
12.19 LIMOR
12.19.1 LIMOR Corporation Information
12.19.2 LIMOR Business Overview
12.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Products Offered
12.19.5 LIMOR Recent Development
12.20 ME VAC
12.20.1 ME VAC Corporation Information
12.20.2 ME VAC Business Overview
12.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Products Offered
12.20.5 ME VAC Recent Development
12.21 Agrovet
12.21.1 Agrovet Corporation Information
12.21.2 Agrovet Business Overview
12.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Products Offered
12.21.5 Agrovet Recent Development

13 Foot and Mouth Disease (FMD) Vaccines Manufacturing Cost Analysis
13.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccines
13.4 Foot and Mouth Disease (FMD) Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Foot and Mouth Disease (FMD) Vaccines Distributors List
14.3 Foot and Mouth Disease (FMD) Vaccines Customers

15 Market Dynamics
15.1 Foot and Mouth Disease (FMD) Vaccines Market Trends
15.2 Foot and Mouth Disease (FMD) Vaccines Drivers
15.3 Foot and Mouth Disease (FMD) Vaccines Market Challenges
15.4 Foot and Mouth Disease (FMD) Vaccines Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の口蹄疫(FMD)ワクチン販売市場2021(Global Foot and Mouth Disease (FMD) Vaccines Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。